Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OXYMORPHONE HYDROCHLORIDE
- Combined Use of Naldebain® ER Injection and Precedex® After VATS
- Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy
- Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
- Naldebain and Video-assisted Thoracoscopic Surgery
- Safety, Tolerability, Effectiveness, and Pharmacokinetic Data in Opioid-experienced Children
- Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population
- Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer
- A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
- Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Thai Pediatric Surgical Patients
- Ibuprofen to Decrease Opioid Use and Post-operative Pain Following Unilateral Inguinal Herniorrhaphy
- Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
- Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
- Analgesia Effects of Nalbuphine vs Sulfentanil
- Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- Evaluate The Pharmacokinetics and Safety Of Oxycodone Oral Solution In Pediatric and Adolescent Subjects
- Bioequivalency Study of Oxymorphone Hydrochloride 10 mg Tablets Under Fasted Conditions
- Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects
- Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Opioid Tolerant Pediatric Subjects
- Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)
- A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone
- Effect of Extended-release Oxymorphone Taking With or Without Food on Cognitive Functioning
- Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain
- Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain
- Open Label Assessment of Long-Term Safety and Utility
- Open-Label Extension to Evaluate the Long-Term Safety, Tolerability and Analgesic Efficacy
- Post-operative Efficacy and Safety Study
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fasted Conditions
- Bioavailability of Oxymorphone Hydrochloride 40 mg Extended Release Tablets Under Fed Conditions
- Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects.
- Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects
- Lumbar Stenosis Outcomes Research II
- A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)
- OXY-2: The Pharmacogenetics of Oxycodone Analgesia in Human Experimental Pain Models
- OXY-1: The Pharmacogenetics of Oxycodone Analgesia in Postoperative Pain
- Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain
- Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain
- Efficacy and Safety of Oxmorphone Extended Release in Chronic Non-malignant Pain
Clinical trials list
click for details